Short-term proof-of-principle trial of ripirivine (TMC278) in patients with HIV-1 infections who previously failed antiretroviral therapy
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Rilpivirine (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Proof of concept; Therapeutic Use
- 05 Nov 2010 New trial record.